The industry urgently needs to understand that its current approach to policy is almost pre-destined to deliver disappointment and poor outcomes.
The choice is to be more defensive or continue to suffer bad outcomes
September 19, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Is this new parliamentary inquiry the latest example of a 'controlling' instinct?
November 23, 2026 - - Latest News -
Former Australian cricketer shares RSV experience as survey reveals gap in personal risk awareness
November 23, 2026 - - Latest News -
Australians unsure of cholesterol levels as campaign challenges heart health myths
November 23, 2026 - -
PBS talks begin under fiscal strains with patients, as always, left outside the room
November 23, 2026 - - Latest News -
While the PBS continues to fall short, we should expect more of these innovative alternatives
November 23, 2026 - - Latest News -
It happened last time, so it makes sense to start next week assuming it as the base case
November 20, 2026 - - Latest News -
Applying the principles of the Reserve Bank review to HTA advisory committees
November 20, 2026 - - Latest News

